Literature DB >> 11339977

Cardiac mechanotransduction: from sensing to disease and treatment.

P Tavi1, M Laine, M Weckström, H Ruskoaho.   

Abstract

In heart muscle a mechanical stimulus is sensed and transformed into adaptive changes in cardiac function by a process called mechanotransduction. Adaptation of heart muscle to mechanical load consists of neurohumoral activation and growth, both of which decrease the initial load. Under prolonged overload this process becomes maladaptive, leading to the development of left ventricular hypertrophy and ultimately to heart failure. Widespread synergism and crosstalk among a variety of molecules and signals involved in hypertrophic signaling pathways make the prevention or treatment of left ventricular hypertrophy and heart failure a challenging task. Therapeutic strategies should include either a complete and continuous reduction of load or normalization of left ventricular mass by interventions aimed at specific targets involved in mechanotransduction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11339977     DOI: 10.1016/s0165-6147(00)01679-5

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  14 in total

1.  Mechanical overload-induced apoptosis: a study in cultured neonatal ventricular myocytes and fibroblasts.

Authors:  Marion Persoon-Rothert; Karlien G C van der Wees; Arnoud van der Laarse
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

2.  Fatty acid synthase modulates homeostatic responses to myocardial stress.

Authors:  Babak Razani; Haixia Zhang; P Christian Schulze; Joel D Schilling; John Verbsky; Irfan J Lodhi; Veli K Topkara; Chu Feng; Trey Coleman; Attila Kovacs; Daniel P Kelly; Jeffrey E Saffitz; Gerald W Dorn; Colin G Nichols; Clay F Semenkovich
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

Review 3.  Cell adhesion receptors in mechanotransduction.

Authors:  Martin A Schwartz; Douglas W DeSimone
Journal:  Curr Opin Cell Biol       Date:  2008-06-24       Impact factor: 8.382

4.  Cardiomyocyte contractile status is associated with differences in fibronectin and integrin interactions.

Authors:  Xin Wu; Zhe Sun; Andrea Foskett; Jerome P Trzeciakowski; Gerald A Meininger; Mariappan Muthuchamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

5.  Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice.

Authors:  Stephane Heymans; Florea Lupu; Sven Terclavers; Bjorn Vanwetswinkel; Jean-Marc Herbert; Andrew Baker; Desire Collen; Peter Carmeliet; Lieve Moons
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

6.  Pacing-induced calcineurin activation controls cardiac Ca2+ signalling and gene expression.

Authors:  Pasi Tavi; Sampsa Pikkarainen; Jarkko Ronkainen; Perttu Niemelä; Mika Ilves; Matti Weckström; Olli Vuolteenaho; Joseph Bruton; Håkan Westerblad; Heikki Ruskoaho
Journal:  J Physiol       Date:  2003-10-17       Impact factor: 5.182

7.  AAV9-mediated VEGF-B gene transfer improves systolic function in progressive left ventricular hypertrophy.

Authors:  Jenni Huusko; Line Lottonen; Mari Merentie; Erika Gurzeler; Andrey Anisimov; Atsushi Miyanohara; Kari Alitalo; Pasi Tavi; Seppo Ylä-Herttuala
Journal:  Mol Ther       Date:  2012-10-23       Impact factor: 11.454

8.  Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy.

Authors:  Dilek Colak; Namik Kaya; Jawaher Al-Zahrani; Albandary Al Bakheet; Paul Muiya; Editha Andres; John Quackenbush; Nduna Dzimiri
Journal:  Genomics       Date:  2009-03-28       Impact factor: 5.736

9.  Characterization of the regulatory mechanisms of activating transcription factor 3 by hypertrophic stimuli in rat cardiomyocytes.

Authors:  Elina Koivisto; Alicia Jurado Acosta; Anne-Mari Moilanen; Heikki Tokola; Jani Aro; Harri Pennanen; Hanna Säkkinen; Leena Kaikkonen; Heikki Ruskoaho; Jaana Rysä
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

10.  Integrated Left Ventricular Global Transcriptome and Proteome Profiling in Human End-Stage Dilated Cardiomyopathy.

Authors:  Dilek Colak; Ayodele A Alaiya; Namik Kaya; Nzioka P Muiya; Olfat AlHarazi; Zakia Shinwari; Editha Andres; Nduna Dzimiri
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.